Shu Chien received premed education at Peking University and his medical degree from National Taiwan University. After receiving his Ph.D. in Physiology from Columbia University, he stayed as a faculty in the Department. In 1988 he was recruited to University of California San Diego, where he is a University Professor of Bioengineering and Medicine and Director of the Institute of Engineering in Medicine. In 1994, he established the Department of Bioengineering and served as the Founding Chair. His research focuses on molecular, cellular and integrative bioengineering, with an emphasis on the mechanisms controlling mechanotransduction, gene expression and epigenetic regulation. He has published six hundred original publications in international scientific journals and edited 16 books.
Chien has served as presidents of American Institute for Medical and Biological Engineering, American Physiological Society, Biomedical Engineering Society, Federation of American Societies of Experimental Biology, International Society of Biorheology, and Microcirculatory Society.
He has received 6 Honorary Doctoral Degrees, 16 Honorary Professorship, the Melville Medal (twice), Revelle Medal, Franklin Medal, and the Founders Award of National Academy of Engineering. He is an Honorary Member of the Chinese Association of Physiological Sciences (Beijing) and Chinese Physiological Society (Taipei). He has received many teaching awards. As directors of NIH training grants at Columbia and UCSD, he has been responsible for the training of hundreds of predoctoral and postdoctoral trainees.
He is a member of National Academy of Sciences, National Academy of Engineering, National Academy of Medicine, American Academy of Arts and Sciences, National Academy of Inventors, and Academia Sinica, as well as a foreign member of Chinese Academy of Sciences. He is a recipient of the National Health Medal and Presidential Prize in Life Sciences from Taiwan, and the National Medal of Science, the highest honor for scientists and engineers in USA, in 2011.
Prof. Andrew D. McCulloch
Dr. Andrew McCulloch is Distinguished Professor of Bioengineering and Medicine at the University of California San Diego, where he joined the faculty in 1987. Dr. McCulloch is a Principal Investigator of the National Biomedical Computation Resource and the Cardiac Atlas Project, Co-Director of the Cardiac Biomedical Science and Engineering Center and Director of the UCSD Interfaces Graduate Training Program and the Interdisciplinary Ph.D. Specialization in Multi-Scale Biology. He served as Vice Chair of the Bioengineering Department from 2002 to 2005 and Chair from 2005 to 2008. He is also a member of the Institute for Engineering in Medicine, the Qualcomm Institute, the Center for Research on Biological Systems, and a Senior Fellow of the San Diego Supercomputer Center.
Dr. McCulloch was educated at the University of Auckland, New Zealand in Engineering Science and Physiology receiving his Ph.D. in 1986. Dr. McCulloch was an NSF Presidential Young Investigator and is a Fellow of the American Institute for Medical and Biological Engineering and a Fellow of the Cardiovascular Section of the American Physiological Society. He has served on the Board of Directors of the Bio-Medical Engineering Society, and is currently Associate Editor of PLoS Computational Biology and co-Editor-in-Chief of Drug Discovery Today: Disease Models. He is also on the Executive Council of the International Union of Physiological Sciences.
Dr. McCulloch’s lab uses experimental and computational models to investigate the relationships between the cellular and molecular structure of cardiac muscle and the electrical and mechanical function of the whole heart during ventricular remodeling, heart failure and arrhythmia. Current interests include developing multi-scale models of myocyte excitation-contraction coupling mechanisms and their regulation by PKA and CaMKII. His group has scaled cellular level models of these processes up to the tissue and organ scales to investigate mechanisms of arrhythmias and ventricular dysfunction associated with targeted gene defects and congestive heart failure. Genetically engineered mice are an important model system for developing and validating these computational models. Important phenotyping techniques in the mouse include optical electrical mapping, isolated muscle mechanics testing and magnetic resonance imaging. The lab is also developing new methods to generate patient-specific models of the failing heart for clinical use. A major area of research in the lab has been the role of cardiac myocyte mechanotransduction mechanisms in the pathogenesis of ventricular hypertrophy and dilated cardiomyopathy.
Prof. Jay D. Humphrey
J.D. Humphrey received the Ph.D. in Engineering Science and Mechanics from The Georgia Institute of Technology and completed a post-doctoral fellowship in Medicine - Cardiovascular at the Johns Hopkins University. He is currently John C. Malone Professor and Chair of Biomedical Engineering at Yale University. His primary technical interest is in vascular mechanics and mechanobiology, especially vascular aging, hypertension, aneurysms, and tissue engineering. He has authored a graduate textbook (Cardiovascular Solid Mechanics) and co-authored both an undergraduate textbook (An Introduction to Biomechanics) and a short handbook (Style and Ethics of Communication in Science and Engineering). He has also co-edited a research text (Cardiovascular Soft Tissue Mechanics), published chapters in 30 other books or encyclopedias, and published nearly 300 archival journal papers. He served for a decade as founding co-editor-in-chief for the international journal Biomechanics and Modeling in Mechanobiology. He also served as a US representative to the World Council for Biomechanics for more than a decade and served as Chair of the US National Committee on Biomechanics. He is a Fellow of the American Institute of Medical and Biological Engineering, American Society of Mechanical Engineers, and International Academy of Medical and Biological Engineering and an elected member of the Connecticut Academy of Science and Engineering.
Prof. Savio L-Y. Woo
Dr. Savio L-Y. Woo is a Distinguished University Professor Emeritus of Bioengineering. He is a member of the National Academy of Medicine (1991) (formerly the Institute of Medicine), the National Academy of Engineering (1994), and the Academia Sinica (1996), only one of four persons who have gained all three of these honors.
After spending 20 years at the University of California, San Diego (UCSD) as a Professor of Surgery and Bioengineering, Dr. Woo arrived at the University of Pittsburgh in 1990, where he was the Founder and Director of the world-renowned Musculoskeletal Research Center (MSRC), a diverse multidisciplinary research and educational center in the Departments of Orthopaedic Surgery and Bioengineering, Swanson School of Engineering.
Dr. Woo received his B.S. degree from Chico State College (1965), and M.S. and Ph.D. degrees (1966, 1971) from the University of Washington. In 1999, Dr. Woo was bestowed an honorary Doctor of Science Degree from the Board of Trustees of the California State University System; and in 2008, an honorary Doctor of Engineering Degree from the Hong Kong Polytechnic University.
Dr. Woo is a pioneer in bioengineering and is renowned for his 50 years of translational research in healing and repair of tissues. Together with his team, they have authored 310 original research papers, 157 book chapters and review articles. Dr. Woo has also edited 12 books. Their work has had a significant impact on the management of ligament and tendon injuries including clinical paradigm shifts that have led to improved patient outcome.
More recently, Dr. Woo’s research focused on two areas: 1) measurement of the forces in the ligament and tendon and their contribution to joint function using robotics technology and 2) using functional tissue engineering (FTE) approach to regenerate ligaments and tendons. Dr. Woo’s team has explored the use of biodegradable magnesium (Mg) and Mg alloys for ligament regeneration. With their pioneering work on the use of robotic technology together with biplanar fluoroscopy, the in-vivo function of the ACL is better characterized and mechanisms of ACL injury can be better understood. Further, improved ways for ACL reconstruction are elucidated and quantitatively based scientific methods for injury prevention could be developed.
Dr. Woo has educated over 500 orthopaedic surgeons, post-doctoral fellows and students from the U.S., Japan, Germany, Greece, Italy, Taiwan, Turkey, Korea, Canada, England, Norway, India, Thailand, Hong Kong SAR, and China. He has also successfully mentored 37 junior faculty members.
Dr. Woo has been a leader in Bioengineering and Orthopaedics. He has served as Chair of ASME’s Bioengineering Division, United States National Committee of Biomechanics, and the World Council for Biomechanics as well as President for the Orthopaedic Research Society, American Society of Biomechanics, and International Society for Fracture Repair. He has also founded the International Symposium on Ligaments and Tendons (ISL&T) and World Association for Chinese Biomedical Engineers (WACBE).
He has received the highest honors from many professional societies, including the Kappa Delta Award (AAOS/ORS), the Herbert R. Lissner Medal (ASME), the O’Donoghue Sports Injury Research Award (AOSSM), the Giovanni Borelli Award (ASB), the Muybridge Medal (ISB), and the prestigious Diamond Award for Distinguish Achievement from the University of Washington, among others. He was also given the IEEE Gold Medal for Innovation in Healthcare Technology from the Institute for Electrical and Electronics Engineers. In 1998, Dr. Woo received the Olympic Prize for Sports Science from the International Olympic Committee and the first Olympic Gold Medal at the Nagano Games in Japan.
The International Symposium on Ligaments and Tendons (ISL&T) honors him with the Savio L-Y. Woo Young Researcher Award; the World Association for Chinese Biomedical Engineers (WACBE) honors him with the Savio L-Y. Woo Distinguished Lectureship; and the American Society for Mechanical Engineers (ASME) honors him with the establishment of the Savio L-Y. Woo Translational Biomechanics Medal.
Prof. Shu Q. Liu
Dr. Shu Q. Liu received PhD in Bioengineering from the University of California at San Diego, CA and is Professor of Biomedical Engineering at Northwestern University, Evanston, IL. Dr. Liu is interested in cardiovascular protective and regenerative engineering in education and research, focusing on mechanical regulation of vascular regeneration, engineering modulation of vascular cell formation and function, and systems protective mechanisms and engineering against ischemic myocardial and neural injuries.
Prof. Geert W. Schmid-Schönbein
Geert W. Schmid-Schönbein is Distinguished Professor and former Chairman of the Department of Bioengineering at the University of California San Diego (UCSD). He studied physics as undergraduate at the Justus Liebig University in Giessen, Germany, and received his Ph.D. degree in Bioengineering at UCSD under the mentorship of Professor Y.C. Fung. Following three years as Post-doctoral Fellow in the Department of Physiology of Columbia University, New York, he joined the faculty of the Department of Bioengineering at UCSD in 1979.
His interest is in biomechanics and molecular/cellular mechanics. He applies bioengineering analysis to human disease focused on the biomechanics of inflammation. His team of students and collaborators discovered a fundamental mechanism for inflammation with cell and organ dysfunctions due to digestive enzymes, a process they coined “Auto-digestion”. Digestive enzymes are a basic requirement in life facilitating daily nutrition and are usually contained in the gastrointestinal tract. But when intestinal barriers are compromised, digestive enzymes will leak out of the intestine. Outside of the intestine these powerful enzymes degrade plasma biomolecules, membrane receptors and glycocalyx structures, which causes loss of cell functions, tissue destruction and even death. With his students he analyzes transport mechanisms by which digestive enzymes leak into the body and how they destroy cells and tissues.
The team also studies early forms of Autodigestion and the role of unchecked degrading protease in Type II Diabetes (Insulin Resistance), Hypertension, as well as co-morbidities that accompany these chronic disease conditions. They develop new interventions against Autodigestion that are tested in clinical trials.
Professor Stephanie I. Fraley
Dr. Stephanie I. Fraley is an Assistant Professor of Bioengineering at the University of California San Diego. She earned her B.S. in Chemical Engineering in 2006 from The University of Tennessee Chattanooga and her Ph.D. in Chemical and Biomolecular Engineering in 2011 from The Johns Hopkins University, where she contributed new understanding to the role of substrate dimensionality in regulating cell migration. Dr. Fraley then joined the Emergency Medicine department at The Johns Hopkins University as a postdoctoral fellow, where she developed novel approaches to sensitively and quantitatively characterize nucleic acids circulating in the bloodstream. Building on this interdisciplinary experience, her current research takes an integrative approach to develop and apply technologies that can improve our understanding of cancer metastasis. Dr. Fraley is the recipient of a Burroughs Wellcome Fund Career Award at the Scientific Interface for merging clinical and basic research technologies as well as an NSF CAREER award for developing integrative, data-driven approaches to study cell-extracellular matrix interactions underlying migration. She has been named a National Academy of Sciences Kavli Frontiers of Science Fellow, Biomedical Engineering Society Cellular and Molecular Bioengineering Rising Star, and SAGE Bionetworks Scholar.
Professor Yingxin Qi
Dean of School of Biological Science and Medical Engineering, Beihang University. The researches of Dr. Qi focus on the mechanisms on which mechanical stimuli induce biological responses and vascular remodelling. Based on the “mechano-vascluar proteomics” researches, Dr. Qi detected the mechanotransduction networks and demonstrated the roles of nuclear envelope proteins in mechanoresponsive effect. The present researches also revealed the epigenetic mechanisms in vascular remodelling induced by mechanical stimuli. The main results were in PNAS, Nano Lett, JMCC. Dr Qi. gained the National Science Fund for Distinguished Young Scholars and the National Natural Science Foundation--Outstanding Youth Foundation, and supported by Program for New Century Excellent Talents in University.
Prof. Cheng Zhu
Dr. Cheng Zhu is J. Erskine Love Jr. Endowed Chair in Engineering and Regents’ Professor of Biomedical Engineering at the Georgia Institute of Technology and Emory University. Dr. Zhu received his B.S. from Zhejiang University, China, in 1982 and M.S. and Ph.D. from Columbia University in 1985 and 1988, respectively. He was Postgraduate Bioengineer and Assistant Bioengineer of the University of California, San Diego in 1988 and 1989, respectively. He joined the faculty of Georgia Tech in 1990 as assistant professor and was promoted to the current rank in 2006. Dr. Zhu’s research interest is in the molecular biophysics of the immune and vascular systems, with focuses in the mechanobiology of T cells and platelets. He pioneered the analysis of interactions at the junctional interface between molecules anchored to two apposing surfaces, i.e., the so-called two-dimensional interaction. His lab conceptualized and/or demonstrated several types of mechanical regulation of protein unbinding and unfolding (catch bonds, force-history, cyclic mechanical reinforcement, and dynamic catch) in a variety of receptor–ligand systems. Dr. Zhu has published ~165 refereed papers, many in high impact journals, including Cell, Nature, Science and their daughter journals. As the Executive Director of the Biomedical Department at GA Tech and Emory University, Dr. Zhu founded the joint doctoral program with Peking University in 2007. It is the first joint doctoral program where students in China and the US are taught the similar curricula, directed by advisors from both China and the US, and awarded Ph.D. degree by the three universities together. Dr. Zhu received the Harold Lamport Award from the Biomedical Engineering Society in 1991, Yuan-Cheng Fung Award from American Mechanical Engineer Society in 1992, Presidential Faculty Fellows Award from National Science Foundation in 1993, and Award in Hemarheology and Microcirculation from International Clinical Society of Hemarheology in 2005. Dr. Zhu is a fellow of the American Institute for Medical and Biological Engineering and a fellow of the Biomedical Engineering Society.
Professor Danny Bluestein
Danny Bluestein, Ph.D. is a Professor of Biomedical Engineering at Stony Brook University, NY. He received his bachelor degree in Aeronautical Engineering from the Technion, Israel, and Ph.D. in biomedical Engineering at Tel Aviv University, Israel. His research interests include the elucidation of physical forces that regulate cellular function in flowing blood, and translation of this knowledge to numerical and experimental strategies aimed at improving the design of blood recirculating devices such as prosthetic heart valves, ventricular assist devices and the total artificial heart, developing multiscale modeling approaches to describe blood clotting, and enhancing clinical diagnostics of cardiovascular diseases by using patient based numerical simulations. He is the author of 130 peer reviewed scientific articles. He served as an associate editor of the ASME Journal of Medical Devices and is a member of the editorial board of Artificial Organs, Expert Review of Medical Devices, and Heart International. He is an active member in the Biomedical Engineering Society, Bioengineering Division of the American Society for Mechanical Engineers where he served as the elected chair of the BED Biofluids technical committee, the Steering Committee of the Multiscale Modeling (MSM) Consortium, and the International Hemodynamic Society. Dr. Bluestein has received several major honors and awards including the Established Investigator Award from the American Heart Association (AHA) and the Quantum award from the NIH-NIBIB. He was elected as a Fellow of the Biomedical Engineering Society (BMES) and Fellow of the American Institute of Medical and Biological Engineering (AIMBE). His research has been sponsored by various federal agencies and private foundations including the National Institutes of Health, the National Science Foundation, and the American Heart Association.
Professor Cheng DONG
Graduated in 1982 with an undergraduate major in Engineering Mechanics from Shanghai Jiao-Tong University, Prof. Dong received his Ph.D in Engineering Science and Bioengineering in 1988 from Columbia University. He is now a Department Head of the Penn State Biomedical Engineering Department, Distinguished Professor of Biomedical Engineering. He was also a Chang-Jiang-Scholar Chair Professor at Shanghai Jiao-Tong University.
Prof. Dong is currently a Member of the United States National Committee on Biomechanics (USNCB); a Fellow of the American Institute of Medical and Biological Engineering (AIMBE); a Fellow of the Biomedical Engineering Society (BMES); a Council Member of the International Society of Biorheology (ISB); a Chair of the BMES Cellular & Molecular Bioengineering (CMBE) Special Interest Group (SIG); a Member of the American Society of Mechanical Engineers (ASME); a Member of the American Association for Cancer Research (AACR), and a Member of the American Physiological Society (APS). Dr. Dong is also a Managing Editor for Frontiers in Bioscience; an Associate Editor for BMES Cellular and Molecular Bioengineering; and an Associate Editor for Molecular and Cellular Biomechanics; as well as an Editorial Member of the Chinese Journal of Medical Biomechanics. Prof. Dong has received several prestigious honors and awards, including the US National Science Foundation (NSF) Faculty Career Award, American Cancer Society Faculty Research Award, ASME Y.C. Fung Young Investigator Award, BMES Harold Lamport Young Investigator Award, ASME Melville Medal, and ASME Best Journal Paper Award.
The major focus of Dr. Dong's research is to elucidate biomechanical, biophysical and biochemical aspects of cellular function in the circulatory systems, with particular interest in cellular biomechanics, cell adhesion, cell migration, cell signaling, systems biology, and multi-scale modeling of biological systems. Current research at Penn State includes studies of micro-hemodynamics, leukocyte rheology, intercellular and intracellular signaling, cancer immunology and metastases. In particular, he is investigating how fluid dynamics, adhesion kinetics and tumor microenvironment change leukocyte and/or endothelial immune functions which subsequently affect tumor cell extravasation in the microcirculation and subsequent metastasis. Most recently, Dr. Dong has involved adoptive immunotherapies using engineered chimeric antigen receptors (CAR) lymphocytes and smart nanoparticles that target brain tumors by delivering drugs through the blood-brain barrier.
Prof. Hai-Chao Han
Dr. Han is the Zachry Endowed Chair Professor and Department Chair of Mechanical Engineering at the University of Texas at San Antonio (UTSA). He received his Ph.D. degree in Solid Mechanics/Biomechanics from Xi’an Jiaotong University in China with joint training from the University of California at San Diego under the tutelage of Professor YC Fung. Dr. Han was an Associate Professor at Xi’an Jiaotong University and a Research Engineer II at Georgia Institute of Technology before joining UTSA in 2003.
Dr. Han’s research interests are in the area of cardiovascular biomechanics with focus on arterial wall mechanics and instability, cardiac mechanics, heart disease and treatment. He has published over 110 peer-reviewed journal papers. He received a CAREER award from NSF in 2007. He is a Fellow of American Heart Association (AHA), College of Fellows of American Institute for Medical and Biological Engineering (AIMBE), and American Society of Mechanical Engineers (ASME).
Prof. Ghassan S. Kassab
Dr. Kassab received his BS (Chemical Engineering), MS (Engineering Sciences) and PhD (Bioengineering, Summa Cum Laude) from University of California, San Diego. Early in his career, he trained with the world-renowned Dr. YC Fung. Dr. Kassab also previously served as the Thomas J. Linnemeier Guidant Foundation Chair and Professor in Biomedical Engineering, Professor in Surgery, Cellular and Integrative Physiology at Indiana University Purdue University, Indianapolis as well as Professor at University of California, Irvine. He is currently the Founder/President/CSO of California Medical Innovations Institute in San Diego and Founder of 3DT Holdings (incubator/accelerator of medical devices). Dr. Kassab is the recipient of the NIH Young Investigator Award, the AHA Established Investigator Award, Farriborz Maseeh Best Research Award, Abraham M. Max Distinguished Professor Award, Eminent Engineer Award of Tau Beta Pi Engineering Honor Society, Indiana’s President Circle Award, and Glenn Irwin, MD Chancellor Best Research Scholar Award. He is also a Fellow of the American Institute for Medical and Biological Engineering, the American Physiological Society Cardiovascular Section and the American Venous Forum. He has served as a regular reviewer on two NIH study sections (Systems Biology; and Hypertension and Microcirculation) and as ad hoc on multiple other study sections; the Editorial Board of American Journal of Physiology-Heart and Circulatory Physiology, Journal of Biomechanics, and has previously served as an Associate Editor of Mechanics and Chemistry of Biosystems. Dr. Kassab has published over 600 proceedings, abstracts and full-length publications and his current scientific interests encompass the biomechanics of cardiovascular and gastroenterology systems in health and disease. He also has over 250 issued or pending patents in the areas of diagnosis and treatment of heart failure (including electrical, valvular and coronary artery disease), aneurysm, and obesity. To date, Dr. Kassab’s intellectual properties have resulted in a sale of one technology, six ongoing start-ups and four exclusive licenses to major medical device industry.
Prof. Mohammad R. K. Mofrad
Dr. Mohammad R. K. Mofrad is Professor of Bioengineering and Mechanical Engineering at the University of California Berkeley. His research program (URL: mechano.bio) is aimed at understanding the molecular basis of human diseases via state-of-the-art molecular and multiscale biomechanics, computational biology, and statistical learning approaches. Mofrad Lab’s multidisciplinary work has appeared in diverse scientific and biomedical engineering journals ranging from Biophysical Journal, Physical Reviews to Integrative Biology, Molecular Biology of the Cell, Scientific Reports, and Digital Medicine. He has co-edited three books, including "Cytoskeletal Mechanics" and "Cellular Mechanotransduction" published by Cambridge University Press. He has served on the editorial boards of several journals, including the Journal of Biomechanics, ASME Journal of Biomechanical Engineering, IEEE Transactions of Biomedical Engineering, BMES Cellular and Molecular Bioengineering, Nature Scientific Reports, and PLoS One. Prof. Mofrad is a recipient of the National Science Foundation (NSF) CAREER award in 2010 and the American Heart Association (AHA) Innovative Research award in 2016. Prof. Mofrad is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and an Invitational Fellow of Japan Society for Promotion of Science (JSPS).
Professor Ning Wang
Professor Ning Wang is the Leonard C and Mary Lou Hoeft Endowed Professor in Engineering, University of Illinois at Urbana-Champaign. Ning Wang conducts research in the area of biomechanics, mechanobiology, and mechanomedicine using novel experimental technologies and theoretical analyses.
Wang co-invented the Magnetic Twisting Cytometry (MTC) technology for probing a single cell’s mechanical properties and discovered in 1993 that the cell-matrix adhesion molecules-integrins are mechanosensors. He provided first experimental evidence that endogenous cytoskeletal stress (prestress) regulates cell shear stiffness and controls gene expression in early 2000’s. He developed 3D-MTC technology to apply forces in any directions and the intracellular strain tomography technology in 2004. In 2008, Wang’s laboratory discovered the long-distance force propagation in live cells and demonstrated fundamental differences between mechanical force-based signaling and soluble growth factor-based signaling. In 2009 his laboratory discovered that an embryonic stem cell differentiates in response to applied forces of physiologic magnitudes. In 2010, Wang and collaborators discovered that cell-cell adhesion molecules E-cadherins are bona fide mechanosensors in living cells. In 2012 Wang’s lab has developed a novel mechanical method that selects a minor subpopulation of cancer cells (called tumor-repopulating cells) that are highly efficient in metastasis; in 2014 his lab elucidated mechanisms that regulate mechanical and biological plasticity of these soft, malignant tumor-repopulating cells. In 2014 Wang’s lab discovered that organized germ layers in early mammalian embryos can be generated from a single embryonic stem cell in culture. In 2016 Wang’s lab discovered that gene expression can be directly upregulated by stretching the chromatin via applying forces to integrins in a living cell. In 2018 Wang and colleagues synthesized and reported a novel small molecule that inhibits malignant metastatic cancer cells in vitro and in vivo. In 2018 Wang’s lab developed a novel method of quantifying 3D tractions in vitro and in vivo using elastic round microgels. According to Google Scholar, Wang’s H-index is 65 and total citations are >18,850 with an average of ~140 citations per article.
Ning Wang received American Physiological Society Scholander Award in 1991 for his contribution to comparative physiology. Wang holds Doctor of Science (Sc.D.) degree in Physiology from Harvard University and M.S. in biomedical engineering and B.S. in biomechanics from Huazhong University of Science and Technology in China.
Professor Padmini Rangamani
Padmini Rangamani is an associate professor in Mechanical Engineering at the University of California, San Diego. She joined the department in July 2014. Earlier, she was a UC Berkeley Chancellor’s Postdoctoral Fellow, where she worked on lipid bilayer mechanics. She obtained her Ph.D. in biological sciences from the Icahn School of Medicine at Mount Sinai. She received her B.S. and M.S. in Chemical Engineering from Osmania University (Hyderabad, India) and Georgia Institute of Technology respectively. She is the recipient of the ARO, AFOSR, and ONR Young Investigator Awards, and a Sloan Research Fellowship for Computational and Molecular Evolutionary Biology, and the Presidential Early Career Award for Scientists and Engineers. She is also the lead PI for a MURI award on Bioinspired low energy information processing from the AFOSR.
Dalin Tang, Worcester Polytechnic Institute, USA;
Betty Liu, Monmouth University, USA; Daniela Valdez-Jasso, University of California, San Diego, USA; Gador Canton, University of Washington, USA; Guixue Wang, Chongqing University, China; Jacques Ohayon, University Savoie Mont-Blanc, France;
Jessica Zhang, Carnegie Mellon University, USA;
Ku, David N, Georgia Institute of Technology, USA;
Linhong Deng, Changzhou University, China;
Lizheng Wang, Beihang University, China;
Luis Cardoso, City College of New York, USA;
Lulu Wang, Hefei University of Technology, China;
Michael Sacks, The University of Texas at Austin, USA;
Peter C-Y Chen, University of California, San Diego, USA;
Xueying Huang, Xiamen University, China;
Yingxiao Peter Wang, University of California, San Diego, USA;